Cryo-Cell International, Inc.

NYSE American:CCEL

Market Cap

USD 41.95 M

Share Price

USD 5.19

Avg Daily Volume

12,523

Change (1 day)

-4.42%

Change (1 year)

-37.47%

Change (YTD)

-29.96%

Cryo-Cell International, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending February 28, 2025: 0.40%

Cryo-Cell International, Inc. Net Income Margin is 0.40% for the Trailing 12 Months (TTM) ending February 28, 2025, a -101.29% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Cryo-Cell International, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending February 29, 2024 was -31.02%, a -454.26% change year over year.
  • Cryo-Cell International, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending February 28, 2023 was 8.76%, a 15.41% change year over year.
  • Cryo-Cell International, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending February 28, 2022 was 7.59%, a -36.50% change year over year.
  • Cryo-Cell International, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending February 28, 2021 was 11.95%, a 41.27% change year over year.
Key data
Date Net Income Margin EBT Margin Operating Income Margin Gross Profit Margin
Market news
Loading...
NYSE American: CCEL

Cryo-Cell International, Inc.

CEO Mr. David I. Portnoy
IPO Date April 4, 1994
Location United States
Headquarters 700 Brooker Creek Boulevard
Employees 82
Sector 🏥 Health Care
Industries
Description

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Similar companies

BSX

Boston Scientific Corporation

USD 106.53

1.86%

SHL.DE

Siemens Healthineers AG

USD 54.95

0.27%

GEHC

GE HealthCare Technologies Inc.

USD 74.38

-0.64%

4543.T

Terumo Corporation

USD 18.70

0.74%

NTRA

Natera, Inc.

USD 167.96

-0.12%

LH

Laboratory Corporation of America Holdings

USD 260.59

1.41%

BAX

Baxter International Inc.

USD 30.39

-0.36%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 39.09

3.96%

ICLR

ICON Public Limited Company

USD 144.56

-1.49%

600010.SS

Inner Mongolia Baotou Steel Union Co., Ltd.

USD 0.25

-0.07%

RGC

Regencell Bioscience Holdings Limited

USD 17.40

-13.82%

6869.T

Sysmex Corporation

USD 17.15

0.36%

ASND

Ascendis Pharma A/S

USD 172.22

-0.42%

EXAS

Exact Sciences Corporation

USD 53.65

3.55%

CTEC.L

ConvaTec Group Plc

USD 3.97

0.08%

GH

Guardant Health, Inc.

USD 50.86

1.66%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 7.80

-2.41%

DIA.MI

DiaSorin S.p.A.

USD 107.84

-1.95%

688617.SS

APT Medical Inc.

USD 41.29

1.54%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-0.29%

LNTH

Lantheus Holdings, Inc.

USD 81.49

0.93%

SOL.MI

SOL S.p.A.

USD 55.30

0.89%

TMDX

TransMedics Group, Inc.

USD 131.45

1.07%

ADMA

ADMA Biologics, Inc.

USD 18.16

-1.30%

LAURUSLABS.NS

Laurus Labs Limited

USD 8.21

3.42%

IPCALAB.NS

Ipca Laboratories Limited

USD 15.58

-0.70%

MCOV-B.ST

Medicover AB (publ)

USD 26.62

3.04%

INSP

Inspire Medical Systems, Inc.

USD 132.41

2.08%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 4.04

2.01%

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 1.95

-0.21%

PFIZER.NS

Pfizer Limited

USD 66.66

0.62%

300676.SZ

BGI Genomics Co., Ltd.

USD 6.85

-0.11%

LALPATHLAB.NS

Dr. Lal PathLabs Limited

USD 32.39

0.97%

ERIS.NS

Eris Lifesciences Limited

USD 19.60

3.84%

LIVN

LivaNova PLC

USD 45.75

-0.11%

300529.SZ

Jafron Biomedical Co.,Ltd.

USD 2.97

-0.59%

600739.SS

Liaoning Cheng Da Co., Ltd.

USD 1.55

0.93%

ALIF-B.ST

AddLife AB (publ)

USD 19.81

3.09%

VIMIAN.ST

Vimian Group AB (publ)

USD 4.15

0.75%

VCYT

Veracyte, Inc.

USD 27.38

2.13%

BAVA.CO

Bavarian Nordic A/S

USD 26.54

-0.57%

0853.HK

MicroPort Scientific Corporation

USD 1.10

-0.01%

300199.SZ

Hybio Pharmaceutical Co., Ltd.

USD 2.27

-0.26%

VITR.ST

Vitrolife AB (publ)

USD 14.82

2.00%

QDEL

QuidelOrtho Corporation

USD 28.87

0.59%

NVCR

NovoCure Limited

USD 18.00

5.26%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 4.02

2.05%

CERT

Certara, Inc.

USD 11.38

-0.35%

ADPT

Adaptive Biotechnologies Corporation

USD 11.79

-3.04%

HRMY

Harmony Biosciences Holdings, Inc.

USD 31.98

0.38%

StockViz Staff

June 30, 2025

Any question? Send us an email